News & Updates
Filter by Specialty:
Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients
A retrospective study of over 6,000 Chinese patients with acute coronary syndrome (ACS) who underwent first-ever percutaneous coronary intervention (PCI) has shown that use of potent P2Y12 inhibitors, such as ticagrelor and prasugrel, is associated with lower risk of stroke than clopidogrel.
Risk of stroke lower with potent P2Y12 inhibitors vs clopidogrel in Chinese ACS patients
08 Apr 2022
Add-on amantadine lessens “off” episodes in Parkinson’s disease
A delayed release/extended release (DR/ER) formulation of amantadine can help reduce breakthrough symptoms in Parkinson’s disease patients when the effect of levodopa therapy wears off, as shown in a recent study.
Add-on amantadine lessens “off” episodes in Parkinson’s disease
06 Apr 2022
Deep learning predicts Alzheimer’s disease up to 4 years before onset
A graph convolutional and recurrent neural network model can identify patients who are likely to develop Alzheimer’s disease at around 80 percent accuracy, according to a recent Singapore study.
Deep learning predicts Alzheimer’s disease up to 4 years before onset
04 Apr 2022
Healthy lifestyle behaviours protect against dementia in AF patients
Patients with new-onset atrial fibrillation (AF) who practice a healthy lifestyle appear to be at lower risk of dementia, a study has shown.
Healthy lifestyle behaviours protect against dementia in AF patients
02 Apr 2022
Cinnamon plus aspirin: A recipe for lowering short-term recurrent stroke risk
In the treatment of patients with mild ischaemic stroke or transient ischaemic attack (TIA), the combination of cinnamon and aspirin outperforms aspirin alone at reducing the risk of 90-day recurrent stroke, as shown in a study.
Cinnamon plus aspirin: A recipe for lowering short-term recurrent stroke risk
01 Apr 2022
Optimal protection in geriatric patients with atrial fibrillation: An expert’s perspective
Geriatric patients with atrial fibrillation (AF) are at increased risk of blood clots that can lodge in the brain and cause fatal strokes. At a recent webinar, Professor Olivier Hanon, Head of Geriatrics Department in Broca Hospital, Paris, France, shared insights on how to optimally protect geriatric patients with AF, with a special focus on direct oral anticoagulants (DOACs), particularly rivaroxaban, for stroke prevention in AF.